A person with irritable bowel syndrome may notice that abdominal pain and altered bowel habits intensify during periods of anxiety, while persistent digestive symptoms can in turn increase distress. Modern medicine describes this reciprocal communication within the gut-brain axis and classifies IBS among disorders of gut-brain interaction. Ayurveda also treats digestion, sensory experience, emotion, sleep, conduct, and mental function as interdependent, but its concepts should be read in their own terms rather than presented as ancient names for the vagus nerve, microbiome, cytokines, or neurotransmitters.

Manovaha Srotas offers a useful Ayurvedic lens for discussing this relationship. In Charaka Samhita, the expression appears in the pathogenesis of Unmada: aggravated Doshas afflict Hridaya, described there as the seat of intellect, and enter the channels carrying mental factors, thereby disturbing Manas. This establishes a classical connection among bodily disturbance, Hridaya, cognition, and mental function. It does not, however, provide a classical map of a modern gut-brain pathway or identify the gastrointestinal tract as the anatomical root of Manovaha Srotas.

Manovaha Srotas: What the Classical Texts State

Srotas are pathways through which substances and functional influences move and transform. Charaka’s Sroto Vimana chapter describes thirteen major bodily channel systems and gives their roots, but it does not list a separate root for Manovaha Srotas. The statement that its root is “Hridaya and the ten sense-organ pathways” combines passages and later interpretations rather than quoting that chapter.

Hridaya nevertheless has an important place in classical psychophysiology. Charaka associates it with consciousness, mind, intellect, sensory and motor activity, and ten great vessels. Those vessels are not ten sensory nerves, and Hridaya should not be translated as the cardiac plexus or equated with vagal circuitry. Ayurveda instead locates mental life within an integrated person in whom Hridaya, Manas, Indriyas, Doshas, nourishment, and behavior affect one another.

Agni, Ama, and Ojas Without Forced Equivalence

Agni is the Ayurvedic principle of digestion and transformation. In clinical reasoning, its state is assessed through appetite, digestion, bowel pattern, tolerance of food, strength, and other features. Ama refers to incompletely processed material or a pathological state arising when digestion and transformation are impaired. Ojas denotes vital essence and stability associated with well-nourished tissues. These concepts can help organize an Ayurvedic assessment, but they are not synonyms for digestive enzymes, bacterial endotoxin, short-chain fatty acids, immunity, or a laboratory biomarker.

For this reason, statements such as “Ama is lipopolysaccharide” or “Ahara Rasa is the Ayurvedic name for microbial SCFAs” are inaccurate. A clinician may compare patterns across systems to generate questions, but analogy is not identity. Ayurveda explains illness through its own network of Agni, Dosha, Dhatu, Mala, Srotas, Satmya, Manas, and causes related to food and conduct; modern neurogastroenterology uses anatomy, physiology, immunology, endocrinology, microbial ecology, and measurable metabolites.

The Modern Gut-Brain Axis

The modern gut-brain axis is a bidirectional communication network involving the gastrointestinal tract, enteric and central nervous systems, autonomic pathways, endocrine signals, immune activity, microbial products, and host metabolism. Its major routes overlap and influence one another rather than operating as four isolated channels.

  1. Neural communication: Vagal and spinal afferents convey information from the viscera, while autonomic outputs influence motility, secretion, barrier function, and immune activity. About 80% of vagal fibers are afferent; this does not mean that 80% of all gut-brain messages travel upward through the vagus.
  2. Endocrine and enteroendocrine signaling: Gut cells release hormones and mediators in response to nutrients and luminal conditions. Most of the body’s serotonin is produced in the intestine, principally by enterochromaffin cells, where it has major local and peripheral functions. Peripheral serotonin should not be described as if it directly supplies brain serotonin.
  3. Immune and barrier signaling: Intestinal epithelial integrity, microbial components, immune cells, and cytokines can participate in systemic and neural communication. Their roles vary by condition, and the presence of “dysbiosis” alone does not establish a single cause of anxiety, depression, cognitive decline, IBS, or inflammatory bowel disease.
  4. Microbial metabolites: Short-chain fatty acids, bile-acid derivatives, indoles, and other metabolites can interact with epithelial, immune, endocrine, and neural pathways. Many mechanisms are well characterized in experimental models, while translation into condition-specific human treatments remains an active field.

Where Ayurveda and Neurogastroenterology Can Meet

The two systems can meet at the level of clinical questions: Does stress alter appetite, pain, sleep, or bowel habit? Does irregular eating worsen symptoms? Are medicines, infection, restriction, or inflammation involved? Such questions support coordinated care without claiming that Prana Vayu is the vagus nerve, Manovaha Srotas an anatomical gut-brain tract, or Ojas an immune molecule.

Ayurvedic management is also not defined by a universal “gut-brain stack.” Assessment traditionally considers Dosha involvement, Agni, Koshtha, the affected Srotas, strength, age, season, habituation, symptoms, and disease stage. A formula appropriate for constipation with dryness may be unsuitable for diarrhea, inflammatory symptoms, pregnancy, liver disease, or a person taking interacting medicines.

Ayurvedic Medicines and the Microbiome Evidence

Several Ayurvedic medicines have been investigated in relation to gut microorganisms, but findings vary by preparation, model, population, and outcome. Laboratory, animal, and pilot data should not be converted into a fixed protocol for anxiety, depression, IBS, or “leaky gut.”

Triphala

Triphala is the classical three-fruit formulation of Amalaki, Bibhitaki, and Haritaki and is recognized in the Ayurvedic Formulary of India. A small randomized human pilot study found that microbiome responses to Triphala were highly individualized rather than a uniform increase in Lactobacillus or Bifidobacterium. A later in-vitro fecal fermentation model detected metabolite changes but no statistically significant overall microbial-profile change. Triphala may therefore be a legitimate subject of microbiome research, but it should not be advertised as a clinically proven selective prebiotic or brain anti-inflammatory treatment. See the site’s Triphala guide for broader formulation context.

Ashwagandha

Ashwagandha is identified in the Ayurvedic Pharmacopoeia of India as Withania somnifera. Claims that it has been shown in humans to repair intestinal tight junctions, increase butyrate-producing bacteria, and correct gut permeability are not established enough to support a gut-brain protocol. Its use should be based on an appropriate Ayurvedic and medical assessment, not on a branded extract dose copied from a study conducted for a different outcome or population.

Brahmi

The Ayurvedic Pharmacopoeia of India identifies Brahmi as Bacopa monnieri. Bacopa has been studied mainly for cognitive outcomes, not as a validated treatment for enteric nervous-system dysfunction or microbiome-driven anxiety. Mechanistic findings concerning acetylcholine, serotonin receptors, or BDNF are largely experimental and do not establish a peripheral gut-originating mechanism in patients. Bacopa can cause gastrointestinal effects such as nausea, abdominal discomfort, increased stool frequency, or diarrhea and may require caution with thyroid treatment and other medicines. See the site’s Brahmi guide for formulation-specific discussion.

Guduchi, Musta, and Basti

Guduchi (Tinospora cordifolia) and Musta (Cyperus rotundus) should not be assigned vagal, tight-junction, GALT, or microbiome effects merely from traditional digestive use or laboratory findings. Guduchi is especially unsuitable for casual self-prescription because clinically apparent liver injury has been reported with Tinospora cordifolia, including severe cases. Basti is classically important in the management of aggravated Vata, but claims that it “reseeds” the microbiome or restores gut permeability are not established clinical facts. Medicated enema procedures require diagnosis, preparation, sterile practice, suitable formulation, and supervision by a qualified Ayurvedic physician.

Prakriti and the Microbiome

Human studies have reported associations between Prakriti groupings and the relative abundance of some microbial taxa, including a study of 272 participants. They do not demonstrate that Prakriti is caused by the microbiome, that each Dosha has a universal bacterial signature, or that constitutional theory arose from gut microbes. Geography, diet, sequencing, and Prakriti assessment can influence the pattern. The site’s Prakriti-microbiome article can be read with these limits in mind.

A Safer Clinical Framework for Gut-Brain Symptoms

Gut symptoms accompanied by anxiety, low mood, sleep disturbance, or cognitive complaints require a differential diagnosis rather than a standard supplement bundle. The following framework preserves Ayurvedic individualization while respecting the present limits of microbiome evidence.

Clinical Component Ayurvedic Relevance Practical Safeguard
History and examination Assess Agni, Koshtha, Dosha pattern, appetite, stool, sleep, stress, strength, Satmya, and disease stage. Exclude red flags and obtain conventional evaluation when symptoms are persistent, severe, inflammatory, or unexplained.
Food and routine Choose digestible, suitable meals in an appropriate quantity and maintain regular timing according to individual tolerance. Avoid extreme elimination diets and introduce fiber gradually when bloating, diarrhea, obstruction risk, or active inflammation is present.
Herbal formulation Select the medicine, form, adjuvant, timing, and duration for the individual pattern rather than for the phrase “gut-brain axis.” Check pregnancy status, liver and kidney disease, allergies, product quality, and herb-drug interactions.
Basti or other Panchakarma Use only when classically indicated after assessing strength, Dosha, disease stage, and procedural suitability. Do not use home enemas as microbiome treatment; procedures belong under qualified supervision.
Mental-health care Address sleep, sensory load, conduct, emotional stress, and supportive mind-directed measures alongside digestive care. Do not replace psychotherapy, psychiatric care, or prescribed medicines with herbs without the treating clinician’s involvement.

Diet and Daily Routine

Modern nutrition recognizes that fermentable fibers can support microbial metabolism and short-chain-fatty-acid production, although tolerance varies. Ayurveda separately emphasizes suitability, digestibility, quantity, timing, season, preparation, and the eater’s condition. A practical plan may include regular meals, adequate hydration, varied minimally processed plant foods as tolerated, sufficient sleep, and gradual rather than abrupt dietary change. Yogurt, buttermilk, raw salads, large fiber loads, fasting, and spices are not universally suitable; they should be chosen according to symptoms, digestion, diagnosis, and medical needs. For the classical dietary framework, see the site’s Agni and digestion guide.

Safety and Disclaimer

This article is educational and does not diagnose or treat IBS, IBD, anxiety, depression, cognitive impairment, or any other condition. Seek medical evaluation for gastrointestinal bleeding, persistent vomiting, fever, dehydration, progressive weight loss, anemia, nocturnal symptoms, severe or localized pain, jaundice, suicidal thoughts, or a marked change in mental state. People with diagnosed gastrointestinal or psychiatric illness should coordinate care among their physician, mental-health professional when applicable, and a qualified Ayurvedic practitioner.

Do not self-prescribe multi-herb protocols, concentrated extracts, Guduchi, or Panchakarma procedures. Bacopa may produce gastrointestinal adverse effects and may interact with thyroid treatment; Tinospora cordifolia has been associated with liver injury; and some Ayurvedic products have contained unsafe levels of lead, mercury, or arsenic. Use properly identified, quality-tested products and disclose every herb and supplement to the clinicians managing your medicines.

Actionable Tip: Keep a two-week record of meal timing, food changes, sleep, stress, abdominal pain, bloating, stool form and frequency, medications, supplements, and mood. Bring the record to a qualified practitioner or healthcare provider. Parallel changes in symptoms can help guide assessment, but they do not by themselves prove a microbiome mechanism or establish that one symptom caused the other.

References

  1. NIDDK
  2. Irritable bowel syndrome and mental health comorbidity – approach to multidisciplinary management (2023), PubMed Central
  3. Charaka Samhita — Unmada Chikitsa
  4. Charaka Samhita — Sroto Vimana
  5. Charaka Samhita — Arthedashmahamooliya Adhyaya
  6. Charaka Samhita — Agni
  7. Charaka Samhita — Ama
  8. Charaka Samhita — Ojas
  9. Charaka Samhita — Ahara vidhi
  10. The Microbiota-Gut-Brain Axis (2019), PubMed
  11. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis (2018), PubMed Central
  12. Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance (2017), PubMed Central
  13. Communication of gut microbiota and brain via immune and neuroendocrine signaling (2023), PubMed Central
  14. The Microbiota-Gut-Brain Axis: From Motility to Mood (2021), PubMed Central
  15. The gut microbiome in disorders of gut-brain interaction (2024), PubMed Central
  16. Ayurvedic Pharmacopoeia of India
  17. CCRAS
  18. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study (2020), PubMed
  19. Efficacy of Triphala extracts on the changes of obese fecal microbiome and metabolome in the human gut model (2023), PubMed Central
  20. Ayurvedic Pharmacopoeia of India
  21. NCCIH
  22. Ayurvedic Pharmacopoeia of India
  23. NCBI
  24. NCBI
  25. Charaka Samhita — Asthapana basti
  26. Ayurvedic Therapies to Target the Microbiome: Evidence and Possibilities (2024), PubMed
  27. Western Indian Rural Gut Microbial Diversity in Extreme Prakriti Endo-Phenotypes Reveals Signature Microbes (2018), PubMed
  28. Exploring the signature gut and oral microbiome in individuals of specific Ayurveda prakriti (2021), PubMed
  29. Prakriti phenotypes as a stratifier of gut microbiome: A new frontier in personalized medicine? (2020), PubMed
  30. The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda (2020), PubMed Central
  31. Mayoclinic (mayoclinic.org)
  32. Ayush (ayush.delhi.gov.in)
  33. NCCIH
Tags: adaptogens Ashwagandha Comparative Study cortisol Rhodiola Stress Hormones